uniQure (QURE) Net Equity Issued and Repurchased (2016 - 2021)
uniQure's (QURE) quarterly Net Equity Issued and Repurchased came in at $2.2 million in Q2 2021, down 14.73% year-on-year from $2.5 million in Q2 2020, and down 92.47% quarter-over-quarter from $28.7 million in Q1 2021.
uniQure (QURE) Net Equity Issued and Repurchased (2016 - 2021) Analysis & Trends
uniQure's Net Equity Issued and Repurchased history runs 6 years deep, the most recent figure standing at $2.2 million for Q2 2021.
- On a quarterly basis, Net Equity Issued and Repurchased fell 14.73% year-over-year to $2.2 million in Q2 2021; TTM through Dec 2021 was $30.9 million, a 315.09% increase from a year earlier, with the FY2021 full-year figure at $30.9 million, up 315.09% from the prior year.
- Net Equity Issued and Repurchased declined to $2.2 million in Q2 2021 per QURE's latest filing, from $28.7 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $28.7 million in Q1 2021 and bottomed at $97000.0 in Q3 2017.
- The 5-year median for Net Equity Issued and Repurchased is $1.5 million (2018), against an average of $2.9 million.
- Across the five-year window, Net Equity Issued and Repurchased tumbled 93.75% in 2018 and jumped 2744.95% in 2021, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $3.0 million in 2017, then tumbled by 93.75% to $188000.0 in 2018, then jumped by 753.72% to $1.6 million in 2019, then surged by 134.02% to $3.8 million in 2020, then tumbled by 42.36% to $2.2 million in 2021.
- Per Business Quant, the three latest QURE Net Equity Issued and Repurchased figures stand at $2.2 million (Q2 2021), $28.7 million (Q1 2021), and $3.8 million (Q4 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 2.17 Mn |
| Jun 30, 2021 | 2.17 Mn |
| Mar 31, 2021 | 28.73 Mn |
| Mar 31, 2021 | 28.73 Mn |
| Dec 31, 2020 | 3.76 Mn |
| Dec 31, 2020 | 3.76 Mn |
| Sep 30, 2020 | 139,000.00 |
| Sep 30, 2020 | 139,000.00 |
| Jun 30, 2020 | 2.54 Mn |
| Jun 30, 2020 | 2.54 Mn |
| Mar 31, 2020 | 1.01 Mn |
| Mar 31, 2020 | 1.01 Mn |
| Dec 31, 2019 | 1.61 Mn |
| Dec 31, 2019 | 1.61 Mn |
| Sep 30, 2019 | 1.28 Mn |
| Sep 30, 2019 | 1.28 Mn |
| Jun 30, 2019 | 543,000.00 |
| Jun 30, 2019 | 543,000.00 |
| Mar 31, 2019 | 2.18 Mn |
| Mar 31, 2019 | 2.18 Mn |